International variations and trends in renal cell carcinoma incidence and mortality
- PMID:25449206
- DOI: 10.1016/j.eururo.2014.10.002
International variations and trends in renal cell carcinoma incidence and mortality
Abstract
Context: Renal cell carcinoma (RCC) incidence rates are higher in developed countries, where up to half of the cases are discovered incidentally. Declining mortality trends have been reported in highly developed countries since the 1990s.
Objective: To compare and interpret geographic variations and trends in the incidence and mortality of RCC worldwide in the context of controlling the future disease burden.
Evidence acquisition: We used data from GLOBOCAN, the Cancer Incidence in Five Continents series, and the World Health Organisation mortality database to compare incidence and mortality rates in more than 40 countries worldwide. We analysed incidence and mortality trends in the last 10 yr using joinpoint analyses of the age-standardised rates (ASRs).
Evidence synthesis: RCC incidence in men varied in ASRs (World standard population) from approximately 1/100,000 in African countries to >15/100,000 in several Northern and Eastern European countries and among US blacks. Similar patterns were observed for women, although incidence rates were commonly half of those for men. Incidence rates are increasing in most countries, most prominently in Latin America. Although recent mortality trends are stable in many countries, significant declines were observed in Western and Northern Europe, the USA, and Australia. Southern European men appear to have the least favourable RCC mortality trends.
Conclusions: Although RCC incidence is still increasing in most countries, stabilisation of mortality trends has been achieved in many highly developed countries. There are marked absolute differences and opposing RCC mortality trends in countries categorised as areas of higher versus lower human development, and these gaps appear to be widening.
Patient summary: Renal cell cancer is becoming more commonly diagnosed worldwide in both men and women. Mortality is decreasing in the most developed settings, but not in low- and middle-income countries, where access to and the availability of optimal therapies are likely to be limited.
Keywords: Incidence; Kidney cancer; Mortality; Registry; Trends.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
- Reporting geographic and temporal trends in renal cell carcinoma: why is this important?Adibi M, Karam JA, Wood CG.Adibi M, et al.Eur Urol. 2015 Mar;67(3):531-2. doi: 10.1016/j.eururo.2014.10.030. Epub 2014 Oct 29.Eur Urol. 2015.PMID:25454608No abstract available.
- Reply from authors re: Mehrad Adibi, Jose A. Karam, Christopher G. Wood. Reporting geographic and temporal trends in renal cell carcinoma: why is this important? Eur Urol 2015;67:531-2: Tackling inequalities in renal cell carcinoma.Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F.Znaor A, et al.Eur Urol. 2015 Mar;67(3):532-3. doi: 10.1016/j.eururo.2014.11.008. Epub 2014 Nov 18.Eur Urol. 2015.PMID:25465971No abstract available.
- Re: International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality.Laguna MP.Laguna MP.J Urol. 2015 Oct;194(4):950-1. doi: 10.1016/j.juro.2015.07.002. Epub 2015 Jul 7.J Urol. 2015.PMID:26382766No abstract available.
Similar articles
- International variations and trends in testicular cancer incidence and mortality.Znaor A, Lortet-Tieulent J, Jemal A, Bray F.Znaor A, et al.Eur Urol. 2014 Jun;65(6):1095-106. doi: 10.1016/j.eururo.2013.11.004. Epub 2013 Nov 14.Eur Urol. 2014.PMID:24268506
- Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, Ng CF, Sung JJ.Wong MC, et al.Eur Urol. 2016 Nov;70(5):862-874. doi: 10.1016/j.eururo.2016.05.043. Epub 2016 Jun 8.Eur Urol. 2016.PMID:27289567
- Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates.Zaccardi F, Dhalwani NN, Webb DR, Davies MJ, Khunti K.Zaccardi F, et al.Diabetologia. 2018 Jul;61(7):1592-1602. doi: 10.1007/s00125-018-4626-y. Epub 2018 May 1.Diabetologia. 2018.PMID:29717336Free PMC article.
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F.Antoni S, et al.Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28.Eur Urol. 2017.PMID:27370177Review.
- Global Burden of Urologic Cancers, 1990-2013.Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C.Dy GW, et al.Eur Urol. 2017 Mar;71(3):437-446. doi: 10.1016/j.eururo.2016.10.008. Epub 2016 Oct 28.Eur Urol. 2017.PMID:28029399Review.
Cited by
- Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.Mourão TC, Abreu D, Carvalhal GF, Gueglio G, da Costa WH, Calsavara VF, Meza-Montoya L, Bengió RG, Scorticati C, Castillejos-Molina R, Rodríguez-Covarrubias F, Autran-Gómez AM, Campos-Salcedo JG, Nolazco A, Ameri C, Zampolli H, Langenhin R, Muguruza D, Machado MT, Mingote P, Clavijo J, Nogueira L, Clark O, Rovegno AR, Secin FP, Decia R, Guimarães GC, Glina S, Rodríguez-Faba O, Palou J, Zequi SC.Mourão TC, et al.BMC Urol. 2020 Jul 2;20(1):85. doi: 10.1186/s12894-020-00649-8.BMC Urol. 2020.PMID:32615971Free PMC article.
- Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.Zheng H, Ji J, Zhao L, Chen M, Shi A, Pan L, Huang Y, Zhang H, Dong B, Gao H.Zheng H, et al.Oncotarget. 2016 Sep 13;7(37):59189-59198. doi: 10.18632/oncotarget.10830.Oncotarget. 2016.PMID:27463020Free PMC article.
- Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.Liu P, Luo J, Zhao L, Fu Q, Chen Y, Li C, Xu J, Yang X.Liu P, et al.PLoS One. 2024 Feb 29;19(2):e0297861. doi: 10.1371/journal.pone.0297861. eCollection 2024.PLoS One. 2024.PMID:38422099Free PMC article.
- Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review.Roussel E, Capitanio U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP, Gorin MA.Roussel E, et al.Eur Urol. 2022 May;81(5):476-488. doi: 10.1016/j.eururo.2022.01.040. Epub 2022 Feb 22.Eur Urol. 2022.PMID:35216855Free PMC article.Review.
- Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma.Vasudev NS, Scelo G, Glennon KI, Wilson M, Letourneau L, Eveleigh R, Nourbehesht N, Arseneault M, Paccard A, Egevad L, Viksna J, Celms E, Jackson SM, Abedi-Ardekani B, Warren AY, Selby PJ, Trainor S, Kimuli M, Cartledge J, Soomro N, Adeyoju A, Patel PM, Wozniak MB, Holcatova I, Brisuda A, Janout V, Chanudet E, Zaridze D, Moukeria A, Shangina O, Foretova L, Navratilova M, Mates D, Jinga V, Bogdanovic L, Kovacevic B, Cambon-Thomsen A, Bourque G, Brazma A, Tost J, Brennan P, Lathrop M, Riazalhosseini Y, Banks RE.Vasudev NS, et al.Clin Cancer Res. 2023 Apr 3;29(7):1220-1231. doi: 10.1158/1078-0432.CCR-22-1936.Clin Cancer Res. 2023.PMID:36815791Free PMC article.
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical